Cargando…
Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences
No abstract available.
Autores principales: | Kleine-Tebbe, Jörg, Klimek, Ludger, Hamelmann, Eckard, Pfaar, Oliver, Taube, Christian, Wagenmann, Martin, Werfel, Thomas, Worm, Margitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787363/ https://www.ncbi.nlm.nih.gov/pubmed/33426427 http://dx.doi.org/10.5414/ALX02215E |
Ejemplares similares
-
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021) -
COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021) -
Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022) -
COVID-19-Impfungen von Patienten mit Allergien und Typ2-entzündlichen Erkrankungen bei gleichzeitiger Antikörpertherapie (Biologika): Ein Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und dem Ärzteverband Deutscher Allergologen (AeDA)
por: Pfaar, Oliver, et al.
Publicado: (2021) -
Biologika und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020)